Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

Shanghai Stock Exchange 600613.SS

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Gross Profit Margin for the year ending December 31, 2023: 49.89%

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Gross Profit Margin is 49.89% for the year ending December 31, 2023, a -5.70% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Gross Profit Margin for the year ending December 31, 2022 was 52.90%, a -12.11% change year over year.
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Gross Profit Margin for the year ending December 31, 2021 was 60.20%, a 1.04% change year over year.
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Gross Profit Margin for the year ending December 31, 2020 was 59.58%, a -5.69% change year over year.
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Gross Profit Margin for the year ending December 31, 2019 was 63.17%, a 3.66% change year over year.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

Shanghai Stock Exchange: 600613.SS

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

CEO	Mr. Feng Bin
IPO Date	Aug. 20, 1992
Location	China
Headquarters	Changfa Tower
Employees	1,426
Sector	Health Care
Industries Pharmaceuticals

Description

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, tonic products, cold and cough, children's medicine, and anti-fungal drugs. Its products include prescription drugs and OTC products. The company was founded in 1992 and is based in Shanghai, China.

Key trends

Past 5 years